About Teletype
Join
Acumen Research
@acumenresearch
Business
February 25, 2020

Assisted Reproductive Technology (ART) Market to Grow at +8% of CAGR By 2026

Assisted Reproductive Technology (ART) Market (By Technology: In-Vitro Fertilization, Artificial Insemination-Intrauterine Insemination, Frozen Embryo Replacement; By End-Use: Hospitals, Fertility Clinics, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast 2019 - 2026

Acumen Research and Consulting, for instance, estimates that this new round of Assisted Reproductive Technology (ART) Market will top $44.59 billion by 2026, representing an average annual growth rate of 8.6 percent.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1741

Acumen Research & Consulting, a global provider of market research studies, in a recently published report titled "Assisted Reproductive Technology (ART) Market (By Technology: In-Vitro Fertilization, Artificial Insemination-Intrauterine Insemination, Frozen Embryo Replacement; By End-Use: Hospitals, Fertility Clinics, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast 2019 to 2026".

North America dominated the global assisted reproductive technology (ART) market in the year 2018. The region has experienced the potential growth owing to the presence of assisted reproductive technology (ART) companies such as Thermo Fisher Scientific, Inc., Cooper Surgical Inc. and OvaScience Inc. among others. The presence of a large customer base along with favorable reimbursement policies is additionally accelerating the regional market growth. Moreover, government support for the treatment and growing number of laboratories and clinic centers are expected to enhance the market growth in the global assisted reproductive technology (ART) market in future. The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) require all biopharmaceutical products and vaccines to undergo stringent testing to ensure the treatment is safe and free of contaminants. Growing prevalence infertility cases further expected to raise the demand for assisted reproductive technology (ART)in North America. The Europe region is expected to exhibit a second-largest share in the assisted reproductive technology (ART) market. R&D investments in new birth technology and growing investment in healthcare industry, growing number of clinic centersin countries, such as Germany, the UK, France, Spain, and Italy, are expected to enhance the market growth in the global assisted reproductive technology (ART)market during the forecast.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/assisted-reproductive-technology-market

Asia-Pacific region is expected to exhibit highest CAGR in the assisted reproductive technology (ART) market. The rapid growth in the urbanization, growing healthcare industry in developing countries, and liberalization of foreign direct investment in the healthcare sector are the major driving factor for the region in the global market. Moreover, the rising awareness about ARTand growing demand for treatment increases its dominance in the global assisted reproductive technology (ART) market in future.

Growing demand for assisted reproductive technology (ART) in various applications, increase demand for new products and drugs in healthcare industry across the globe and rising number of pharmaceutical and biological firmsare the main drivers for the market growth of the global assisted reproductive technology (ART) market over the forecast period. Furthermore, supportive government investment in life science and growing number of laboratory and research centers further grows the demand for assisted reproductive technology (ART) over the forecast the period. Moreover, technological advancement and increase in the number of applications, and availability of advanced healthcare facilities in developing countries are expected to enhance the market size. This also expected to open investment opportunities in the global market for the manufacturers in the coming years.

However, high cost of treatment and lower success rate of treatment, time consuming process are expected to hamper the growth of the global assisted reproductive technology (ART) market during the forecast period.

Fertility clinics segment have dominated the end-use segment in the year 2018 and the segment is projected to maintain its dominance over the forecast period from 2019 to 2026. The end-use segment further classified intohospitals, fertility clinics, and others. Several guidelines and recommendations issued by regulatory authorities, growing number of clinics and laboratories across the globe, and escalating demand for new technology advancement in infertility further expected to drive the demand for the segment.

Related Reports

In-Vitro Fertilization segment dominated the assisted reproductive technology (ART) market on the basis of technology in the year 2018. The major factors that are driving the growth of this segment are high procedural success rate coupled with continuous advancements in IVF technology and growing number of test centers and laboratories drives the demand for new technologyacross the globe. This expected to enhance the dominance of the in-vitro fertilization in the global market over the forecast period.The manufacturers such as Vitro Life, Cooper Surgical Inc., Genea Limited, Cook Medical, and Hamilton Thorne are the mainly investing in the development of in-vitro fertilization, which expected the lead the market in the coming years.

Some of the leading competitors are IVFtechApS, Irvine scientific, Merck, Nidacon International AB, OvaScience Inc., Thermo Fisher Scientific, Inc., Vitro Life, Cooper Surgical Inc., Genea Limited, Cook Medical, and Hamilton Thorne.

Some of the key observations regarding assisted reproductive technology (ART) industry include:

  • In September 2018, Merck KGaA announced opening of new scientific laboratory in Singapore. This expansion of new laboratory focuses on developing new treatment technology and enhance customer base.
  • In April 2018, Thermo Fisher Scientific Inc.launched new cloud-enabled biological safety cabinet. This product is designed to fortify workflow connectivity and contamination control and helped company to enhance its customer base in assisted reproductive technology (ART) market.

Market Segmentation

Market By Technology

  • In-Vitro Fertilization
  • Artificial Insemination-Intrauterine Insemination
  • Frozen Embryo Replacement

Market By End-Use

  • Hospitals
  • Fertility Clinics
  • Others

Market By Geography

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • France
  • Spain
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

- What is the overall structure of the market?

- What was the historical value and what is the forecasted value of the market?

- What are the key product level trends in the market?

- What are the market level trends in the market?

- Which of the market players are leading and what are their key differential strategies to retain their stronghold?

- Which are the most lucrative regions in the market space?

Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1741

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Assisted Reproductive Technology (ART)
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Assisted Reproductive Technology (ART) Market By Technology
1.2.2.1. Global Assisted Reproductive Technology (ART) Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global Assisted Reproductive Technology (ART) Market Revenue Share By Technology in 2018
1.2.2.3. In-Vitro Fertilization
1.2.2.4. Artificial Insemination-Intrauterine Insemination
1.2.2.5. Frozen Embryo Replacement
1.2.3. Assisted Reproductive Technology (ART) Market By End-Use
1.2.3.1. Global Assisted Reproductive Technology (ART) Market Revenue and Growth Rate Comparison By End-Use (2015-2026)
1.2.3.2. Global Assisted Reproductive Technology (ART) Market Revenue Share By End-Use in 2018
1.2.3.3. Hospitals
1.2.3.4. Fertility Clinics
1.2.3.5. Others
1.2.4. Assisted Reproductive Technology (ART) Market by Geography
1.2.4.1. Global Assisted Reproductive Technology (ART) Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Assisted Reproductive Technology (ART) Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Assisted Reproductive Technology (ART) Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Assisted Reproductive Technology (ART) Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Assisted Reproductive Technology (ART) Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Assisted Reproductive Technology (ART) Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Assisted Reproductive Technology (ART) Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Assisted Reproductive Technology (ART) Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Assisted Reproductive Technology (ART) Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Assisted Reproductive Technology (ART) Major Manufacturers in 2018

CHAPTER 4. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY TECHNOLOGY
4.1. Global Assisted Reproductive Technology (ART) Revenue By Technology
4.2. In-Vitro Fertilization
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Artificial Insemination-Intrauterine Insemination
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Frozen Embryo Replacement
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)


CHAPTER 5. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY END-USE
5.1. Global Assisted Reproductive Technology (ART) Revenue By End-Use
5.2. Hospitals
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Fertility Clinics
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY COUNTRY
6.1. North America Assisted Reproductive Technology (ART) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Assisted Reproductive Technology (ART) Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Assisted Reproductive Technology (ART) Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY COUNTRY
7.1. Europe Assisted Reproductive Technology (ART) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Assisted Reproductive Technology (ART) Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY COUNTRY
8.1. Asia-Pacific Assisted Reproductive Technology (ART) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Assisted Reproductive Technology (ART) Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY COUNTRY
9.1. Latin America Assisted Reproductive Technology (ART) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Assisted Reproductive Technology (ART) Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.4. Mexico
9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY COUNTRY
10.1. Middle East & Africa Assisted Reproductive Technology (ART) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East & Africa Assisted Reproductive Technology (ART) Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. GCC
10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.4. South Africa
10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.5. Rest of Middle East & Africa
10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE
11.1. Vitro Life
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Cooper Surgical Inc.
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Genea Limited
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Cook Medical
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Hamilton Thorne
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. IVFtech ApS
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Irvine scientific
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Merck
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Nidacon International AB
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. OvaScience Inc
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Thermo Fisher Scientific, Inc
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
11.12. Others
11.12.1. Company Snapshot
11.12.2. Overview
11.12.3. Financial Overview
11.12.4. Product Portfolio
11.12.5. Key Developments
11.12.6. Strategies

CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1741

If you would like to place an order or have any questions, please feel free to contact at sales@acumenresearchandconsulting.com | +1-407-915-4157 OR +1-408-900-9135

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Contact Us:

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com

Follow Us: LinkedIN | Twitter

Acumen Research
February 25, 2020, 12:23
0 views
0 reactions
0 replies
0 reposts